Patent: 8,324,157
✉ Email this page to a colleague
Summary for Patent: 8,324,157
| Title: | Preparation comprising insulin, nicotinamide and an amino acid |
| Abstract: | Insulin preparations comprising an insulin compound or a mixture of two or more insulin compounds, a nicotinic compound and an amino acid. |
| Inventor(s): | Olsen Helle Birk, Havelund Svend, Ribel-Madsen Ulla, Sturis Jeppe, Naver Helle, Schlein Morten, Ludvigsen Svend |
| Assignee: | Novo Nordisk A/S |
| Application Number: | US13309134 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: |
More… ↓ |
Details for Patent 8,324,157
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Seqirus Inc. | FLUAD | influenza vaccine, adjuvanted | Injection | 125510 | November 24, 2015 | ⤷ Start Trial | 2031-12-01 |
| Seqirus Inc. | FLUAD,FLUAD QUADRIVALENT | influenza vaccine, adjuvanted | Injection | 125510 | February 21, 2020 | ⤷ Start Trial | 2031-12-01 |
| Novo Nordisk Inc. | FIASP | insulin aspart | Injection | 208751 | September 29, 2017 | ⤷ Start Trial | 2031-12-01 |
| Novo Nordisk Inc. | FIASP | insulin aspart | Injection | 208751 | September 24, 2018 | ⤷ Start Trial | 2031-12-01 |
| Novo Nordisk Inc. | FIASP | insulin aspart | Injection | 208751 | June 21, 2023 | ⤷ Start Trial | 2031-12-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,324,157
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201108942 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2010149772 | ⤷ Start Trial |
| United States of America | 2012135920 | ⤷ Start Trial |
| United States of America | 2013281364 | ⤷ Start Trial |
| United States of America | 2014206610 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
